Vertex Pharmaceuticals Stock Forecast

Buy or Hold candidate since Jun 04, 2026 Gain 8.77%

The Vertex Pharmaceuticals Incorporated stock price fell by -1.06% on the last day (Monday, 20th Jul 2026) from $485.65 to $480.50. During the last trading day the stock fluctuated 2.66% from a day low at $478.48 to a day high of $491.23. The price has fallen in 8 of the last 10 days and is down by -9.27% for this period. Volume fell on the last day along with the stock, which is actually a good sign as volume should follow the stock. On the last day, the trading volume fell by -402 thousand shares and in total, 1 million shares were bought and sold for approximately $529.28 million.

The stock lies in the lower part of a wide and strong rising trend in the short term, and this may normally pose a very good buying opportunity. If the lower trend floor at $466.31 is broken, it will firstly indicate a slower rate of rising, but may also be an early warning for a trend shift. Given the current short-term trend, the stock is expected to rise 16.94% during the next 3 months and, with a 90% probability hold a price between $545.28 and $634.35 at the end of this 3-month period.

VRTX Signals & Forecast

The Vertex Pharmaceuticals Incorporated stock holds a sell signal from the short-term Moving Average; at the same time, however, there is a buy signal from the long-term average. Since the short-term average is above the long-term average there is a general buy signal in the stock giving a positive forecast for the stock. On further gains, the stock will meet resistance from the short-term Moving Average at approximately $481.60. On a fall, the stock will find some support from the long-term average at approximately $470.83. A break-up through the short-term average will send a buy signal, whereas a breakdown through the long-term average will send a sell signal. Some negative signals were issued as well, and these may have some influence on the near short-term development. A sell signal was issued from a pivot top point on Monday, July 06, 2026, and so far it has fallen -9.27%. Further fall is indicated until a new bottom pivot has been found. Furthermore, there is currently a sell signal from the 3 month Moving Average Convergence Divergence (MACD). Volume fell together with the price during the last trading day and this reduces the overall risk as volume should follow the price movements.

Support, Risk & Stop-loss for Vertex Pharmaceuticals Incorporated stock

Vertex Pharmaceuticals Incorporated finds support from accumulated volume at $466.79 and this level may hold a buying opportunity as an upwards reaction can be expected when the support is being tested.

This stock has average movements during the day and with good trading volume, the risk is considered to be medium. During the last day, the stock moved $12.75 between high and low, or 2.66%. For the last week, the stock has had daily average volatility of 2.43%.

Our recommended stop-loss: $451.51 (-6.03%) (This stock has medium daily movements and this gives medium risk. There is a sell signal from a pivot top found 10 days ago.)

Trading Expectations (VRTX) For The Upcoming Trading Day Of Tuesday 21st

For the upcoming trading day on Tuesday, 21st we expect Vertex Pharmaceuticals Incorporated to open at $483.40, and during the day (based on 14 day Average True Range), to move between $473.56 and $487.44, which gives a possible trading interval of +/-$13.88 (+/-2.93%) up or down from last closing price. If Vertex Pharmaceuticals Incorporated takes out the full calculated possible swing range there will be an estimated 2.93% move between the lowest and the highest trading price during the day.

Since the stock is closer to the resistance from accumulated volume at $491.34 (2.26%) than the support at $466.79 (2.85%), our systems don't find the trading risk/reward intra-day attractive and any bets should be held until the stock is closer to the support level.

Is Vertex Pharmaceuticals Incorporated stock A Buy?

Several short-term signals, along with a general good trend, are positive and we conclude that the current level may hold a buying opportunity as there is a fair chance for Vertex Pharmaceuticals Incorporated stock to perform well in the short-term. We have upgraded our analysis conclusion for this stock since the last evaluation from a Hold to a Buy candidate.

Current score: 2.487 Buy Candidate Upgraded

Predicted Fair Opening Price

Predicted fair opening price on July 21, 2026 - $483.40 ( 0.604%).

Want to trade but not sure how? Our step-by-step guide can help.
Skip the guide? Open account with our trusted broker*
*Your capital is at risk